IP Library › Assignment 015788/0150
Patent Assignment
Reel/Frame 015788/0150

Assignment of Assignor's Interest

Recorded: 2004-09-16 Pages: 12
Assignor
Assignee
ASTRAZENECA UK LIMITED
15 STANHOPE GATE, LONDON, ENGLAND, W1K 1LN, UNITED KINGDOM
Covered Properties (23)
Phenol Derivatives
Patent: 4,732,912 →
Application: 06/604,964 →
Ether and Ester Derivatives of Phenols
Patent: 4,760,061 →
Application: 06/726,823 →
Phenol Derivatives
Patent: 4,751,240 →
Application: 06/726,824 →
Biodegradable Amphipathic Copolymers
Patent: 4,745,160 →
Application: 06/747,173 →
Continuous Release Pharmaceutical Compositions Formed by Freeze Drying Acetic Acid Solutions of Polylactide
Patent: 5,004,602 →
Application: 06/861,839 →
Continuous Release Pharmaceutical Compositions
Patent: 4,767,628 →
Application: 07/068,760 →
Phenol Derivatives
Patent: 4,904,661 →
Application: 07/134,320 →
Biodegradable Amphipathic Copolymers
Patent: 4,877,606 →
Application: 07/145,116 →
Phenol Derivatives
Patent: 5,021,414 →
Application: 07/452,069 →
Continuous Release Pharmaceutical Compositions
Patent: 5,366,734 →
Application: 07/751,584 →
Carbamoyl Derivatives
Patent: 5,286,740 →
Application: 07/927,762 →
Carbamoyl Derivatives
Patent: 5,334,765 →
Application: 08/137,245 →
Pyridazinedione Compounds Useful in Treating Neurological Disorders
Patent: 5,604,227 →
Application: 08/421,133 →
Pyridazinedione Compounds Useful in Treating Neurological Disorders
Patent: 5,599,814 →
Application: 08/427,469 →
Process for Making Peptides
Patent: 5,602,231 →
Application: 08/452,096 →
Pyridazinedione Compounds Useful in the Treating Neurological Disorders
Patent: 5,733,910 →
Application: 08/689,259 →
Pyridazinedione Compounds Useful in Treating Neurological Disorders
Patent: 5,739,133 →
Application: 08/700,654 →
Peptide Derivatives
Patent: 6,355,617 →
Application: 09/308,175 →
Crystalline Dibenzothiazepine Derivative and Its Use as an Antipsychotic Agent
Patent: 6,372,734 →
Application: 09/463,452 →
One Post Synthesis of 2-Oxazolidinone Derivatives
Patent: 6,909,005 →
Application: 09/659,683 →
Method for Detecting Allelic Imbalance
Patent: 6,586,181 →
Application: 09/673,465 →
Peptide derivatives
Application: 10/078,458 →
Publication: US 2002/0187934
Crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
Application: 10/101,948 →
Publication: US 2002/0147186
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jan 18, 2002
From: ZENECA LIMITED
To: SYNGENTA LIMITED
Reel/Frame 012486/0121 →
Change of Name May 28, 2004
From: ZENECA LIMITED
To: SYNGENTA LIMITED
Reel/Frame 015355/0705 →
Assignment of Assignor's Interest Sep 16, 2004
From: IMPERIAL CHEMICAL INDUSTRIES PLC
To: SYNGENTA LIMITED (FORMERLY, ZENECA LIMITED)
Reel/Frame 015788/0122 →
Change of Name Sep 16, 2004
From: ZENECA LIMITED
To: SYNGENTA LIMITED
Reel/Frame 015788/0146 →
Assignment of Assignor's Interest May 10, 2005
From: ZENECA LIMITED (NOW SYNGENTA LIMITED)
To: ASTRAZENECA UK LIMITED
Reel/Frame 016547/0256 →